{"id":"clm_45682B5E540D","entity":"abbvie","predicate":"chair","value":"Robert A. Michael","value_json":{"accn":"0001104659-26-033387","form":"DEF 14A","item":"proxy: executive officers","check":{"on":"2026-11-13","url":"https://www.sec.gov/Archives/edgar/data/1551152/000110465925047402/0001104659-25-047402-index.htm","pages":3,"quote":"On February 14, 2025, AbbVie filed a Form 8-K to announce that the Board elected Robert A. Michael to succeed Mr. Gonzalez as the Company’s Chairman, effective July 1, 2025.","outcome":"checked"},"filed":"2026-03-23","quote":"Robert A. Michael Director Since: 2024 Age: 55 Primary Occupation: Chairman of the Board and Chief Executive Officer, AbbVie Inc. Business Experience: Mr. Michael is AbbVie’s Chairman and Chief Executive Officer, a position he has held since July 2025.","baseline":true,"precision":10},"valid_from":"2025-07-01","valid_to":null,"published":"2025-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"AbbVie chair: Robert A. Michael\", as of 2025-07-01. Claim clm_45682B5E540D, https://asof.is/claim/clm_45682B5E540D, accessed 2026-11-13. Source: https://www.sec.gov/Archives/edgar/data/1551152/000110465925013467/0001104659-25-013467-index.htm.","url":"https://asof.is/claim/clm_45682B5E540D","accessed":"2026-11-13"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"supersedes":[],"first_seen_at":"2026-11-08T19:32:35.286918+00:00","updated_at":"2026-11-13T05:33:43.642612+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1551152/000110465925013467/0001104659-25-013467-index.htm","tier":"primary","publisher":"SEC EDGAR 8-K Item 5.02","published_at":"2025-02-14T00:00:00+00:00"},{"url":"https://www.sec.gov/Archives/edgar/data/1551152/000110465926033387/abbv-20260508xdef14a.htm","tier":"primary","publisher":"SEC EDGAR DEF 14A","published_at":"2026-03-23T00:00:00+00:00"},{"url":"https://www.sec.gov/Archives/edgar/data/1551152/000110465925047402/0001104659-25-047402-index.htm","tier":"primary","publisher":"SEC EDGAR 8-K Item 5.02","published_at":"2025-05-13T00:00:00+00:00"}],"evidence":{"by":"page-read","on":"2026-11-13","quote":"On February 14, 2025, AbbVie filed a Form 8-K to announce that the Board elected Robert A. Michael to succeed Mr. Gonzalez as the Company’s Chairman, effective July 1, 2025.","url":"https://www.sec.gov/Archives/edgar/data/1551152/000110465925047402/0001104659-25-047402-index.htm"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"page-read":"its source page states the value and the date, as read by an AI model"}}}